BackIntercept Pharmaceuticals Overview

Intercept Pharmaceuticals Total Revenue

Intercept Pharmaceuticals's total revenue is $290M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$88.79M
↑ 14.44% YoY

As of Sep 2023

Annual Revenue (TTM)

$288.25M
↓ 12.74% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Intercept Pharmaceuticals (ICPT) FAQ

The latest total revenue for ICPT is $290M as of September 2023. That compares with $330M in the prior-year period — down 12.7% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Intercept Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ICPT's total revenue moved from $330M to $290M — a 12.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intercept Pharmaceuticals's operating scale or balance-sheet position.

Against Healthcare companies, ICPT currently prints $290M for total revenue, while the sector average sits near $110B. That is roughly 99.7% below the sector mean. Large gaps often invite a closer look at Intercept Pharmaceuticals's growth, margins, and balance sheet.

A total revenue figure of $290M for ICPT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting ICPT's total revenue ($290M), review year-over-year change from $330M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.